🗂️
Archived grant — no longer open
This grant has closed and is kept as a historical reference. Browse current grants for active opportunities.
grant
Project 05: Translational Therapeutics (TT)
Organization OHIO STATE UNIVERSITYLocation Columbus, UNITED STATESPosted 12 Sept 1997Deadline 30 Nov 2025 ⚠️
NIHUS FederalResearch GrantFY202521+ years oldAbbreviationsAdultAdult HumanAwardBasic ResearchBasic ScienceBiologicalBiometricsBiometryBiostatisticsBody TissuesBreast CancerCCSGCancer BiologyCancer CauseCancer Center Support GrantCancer ControlCancer Control ScienceCancer EtiologyCancersCatchment AreaCenter for Cancer ResearchCessation of lifeCheckpoint inhibitorChemopreventionChildhoodChildren's HospitalClinicalClinical TreatmentClinical TrialsCollaborationsColorectal CancerComparative PathologyComprehensive Cancer CenterDNA Molecular BiologyDeathDecision MakingDiagnosisDirect CostsDisciplineDiseaseDisorderDoctor of PhilosophyExhibitsFemale Reproductive CancerFlow CytofluorometriesFlow CytofluorometryFlow CytometryFlow MicrofluorimetryFlow MicrofluorometryFundingFutureGI cancersGI malignanciesGI tract cancersGastrointestinal CancerGastrointestinal Tract CancerGeneralized GrowthGenomicsGlioblastomaGoalsGrade IV Astrocytic NeoplasmGrade IV Astrocytic TumorGrade IV AstrocytomaGrantGrowthGynecologic CancerGynecological CancerHead and Neck CancerHead and Neck CarcinomaHost-Tumor InteractionImmune checkpoint inhibitorImmune systemImmunogenomicsImmunooncologyImmunotherapeutic agentInstitutionInterventionIntramural ProgramIntramural Research ProgramIntratumoral heterogeneityInvestigatorsJournalsMagazineMalignant Breast NeoplasmMalignant CellMalignant Female Reproductive System NeoplasmMalignant Gastrointestinal NeoplasmMalignant Gynecologic NeoplasmMalignant Gynecologic TumorMalignant Head and Neck NeoplasmMalignant NeoplasmsMalignant Soft Tissue NeoplasmMalignant Thyroid Gland NeoplasmMalignant TumorMalignant Tumor of the Female Reproductive SystemMalignant Tumor of the LungMalignant Tumor of the ThyroidMalignant Tumor of the Thyroid GlandMalignant neoplasm of gastrointestinal tractMalignant neoplasm of lungMalignant neoplasm of thyroidMedicinal ChemistryMedicineMicroscopyMolecularMolecular BiologyMolecular CarcinogenesisMorbidityMorbidity - disease rateNCCNNCI Center for Cancer ResearchNCI OrganizationNSCLCNSCLC - Non-Small Cell Lung CancerNational Cancer InstituteNational Comprehensive Cancer NetworkNational Institutes of HealthNon-Small Cell Lung CancerNon-Small-Cell Lung CarcinomaOhioOncologyOncology CancerOutcomePatientsPediatric HospitalsPeer ReviewPeer Review GrantsPh.D.PhDPharmaceutic ChemistryPharmaceutical ChemistryPharmaciesPharmacy facilityPhysiciansPrognosisProliferatingProteomicsPublicationsPublishingPulmonary CancerPulmonary malignant NeoplasmResearchResearch PersonnelResearch PriorityResearchersResistanceResource SharingSarcomaScientific PublicationScientistServicesSignal PathwaySolid NeoplasmSolid TumorTCGAThe Cancer Genome AtlasTherapeuticThyroid CancerTissue GrowthTissuesTrainingTranslatingTranslational ResearchTranslational ScienceUnited States National Institutes of HealthUniversitiesValidationVeterinary Medicineadulthoodanimal imagingbiologicbiomed informaticsbiomedical informaticscancer carecancer cellcancer progressionclinical interventionclinical therapycollegecollegiatecolon cancer preventioncomputer imagingdigital imagingdrug developmentflow cytophotometrygastrointestinal malignanciesglioblastoma multiformegynecologic malignancygynecological malignancyhead/neck cancerheterogeneity in tumorshost neoplasm interactionimmune check point inhibitorimmune drugsimmune-based therapeuticsimmune-oncologyimmuno oncologyimmunologic therapeuticsimmunology oncologyimmunotherapeuticsimmunotherapy agentimprovedinnovateinnovationinnovativeinterestintra-tumoral heterogeneityintratumor heterogeneityinvestigator-initiated trialleukemialife spanlifespanlung cancermalignancymalignant breast tumormalignant head and neck tumormalignant soft tissue tumormeetingmeetingsmembermortalitymultidisciplinaryneoplasm progressionneoplasm/cancerneoplastic progressiononcoimmunologyontogenypathology imagingpediatricpre-clinical studypreclinical studyprevent colon cancerprognosticprogramsrecruitresistantresponse to therapyresponse to treatmentsmall moleculespongioblastoma multiformetherapeutic responsetherapeutic targettherapy responsetranslation researchtranslational goaltranslational investigationtranslational missiontranslational therapeuticstranslational therapytreatment responsetreatment responsivenesstrial regimentrial treatmenttumortumor heterogeneitytumor progressionvalidations
Applications closed.
Description preview
PROJECT SUMMARY – TRANSLATIONAL THERAPEUTICS (TT)
The Translational Therapeutics (TT) Program at The Ohio State University Comprehensive Cancer Center
(OSUCCC), co-led by David Carbone, MD, PhD, Blake Peterson, PhD, and Elaine Mardis, PhD, unites an
outstanding team of 79 basic, translational and/or clinical researchers from 18 departments within…
🔒
Start 7-day free trial — $29.99/mo →Full details available on the Agency plan
Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.
Agency Plan
7-day free trialUnlock procurement & grants
Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.
$29.99 / month
- 🔔Email alerts for new matching tenders
- 🗂️Track tenders in your pipeline
- 💰Filter by contract value
- 📥Export results to CSV
- 📌Save searches with one click